Description
Sofosbuvir and Velpatasvir, marketed under the brand name EPCLUSA, It is an prescription medication that has been approved the combination of sofosbuvir and velpatasvir, also known as Epclusa, on June 28, 2016. Epclusa is a direct-acting antiviral (DAA) that treats chronic hepatitis C virus (HCV) in adults.
What is EPCLUSA (sofosbuvir and velpatasvir) ?
EPCLUSA is a fixed-dose combination of sofosbuvir, a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor, and velpatasvir, an HCV NS5A inhibitor, and is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic HCV genotype 1, 2, 3, 4, 5, or 6 infection : • without cirrhosis or with compensated cirrhosis • with decompensated cirrhosis for use in combination with ribavirin.
How to order approved “EPCLUSA (sofosbuvir and velpatasvir) for Tablets” Medicine?
EPCLUSA (sofosbuvir and velpatasvir) Tablets is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing EPCLUSA and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
We can ship to :
Verve Biosciences offers assistance in importing the anti-cancer medication EPCLUSA (sofosbuvir and velpatasvir) for Tablets. To inquire about the total cost of EPCLUSA (sofosbuvir and velpatasvir) for Tablets in various countries, including UAE, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, as well as Europe (such as UK, Hungary, Ireland, Latvia, Slovakia, Czech Republic, Belgium, Lithania, Greece, Spain, Maldova, Germany, Sweden, Italy, Bulgaria, Romania, Montenegro, Russia), and other countries like Zimbabwe, Australia, and New Zealand, Canada, Philippines, USA, South Africa, Thailand, China, Pakistan, Kazakhstan, Uzbekistan, Zambia, Kuwait, Sri Lanka, Singapore, Hong Kong, Afghanistan, Turkey, Malaysia, Qatar, Japan, Nepal, and many other countries. please reach out to us. We will provide you with the necessary information regarding the pricing and availability of EPCLUSA (sofosbuvir and velpatasvir) for Tablets in the desired locations.
How to Get Access
If the Brand Name medication “EPCLUSA (sofosbuvir and velpatasvir) for Tablets” is not approved or unavailable in your country, patients, physicians, and distributors/suppliers have the option to purchase and import it from Verve Biosciences. To begin the process, you can make an enquiry, and we will assist you in calculating the total cost to buy “EPCLUSA (sofosbuvir and velpatasvir) for Tablets” online and arrange delivery to your location. To proceed, we will require a prescription from your treating doctor, and in certain countries, an import license may also be necessary. Throughout the process, our Patient Support team will provide guidance and support.
Verve Biosciences Pvt. Ltd.
Contact Person : Mr Rakesh Khanna
Email: info@cancermedicinesnetwork.com
Mobile: 91 9910645395
WhatsApp: +919910645395
FAQ's
How much does EPCLUSA cost?
The EPCLUSA price in India usually can vary depending on the wholesaler/pharmacy you visit. EPCLUSA is available as a brand name drug only, a generic version is not yet available.
What is the best price for sofosbuvir and velpatasvir?
Please contact at urgent@cancermedicinesnetwork.com : (+91) 9910645395 for sofosbuvir and velpatasvir price India. We take the guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Can I get EPCLUSA (sofosbuvir and velpatasvir) for Tablets even if I am not based in India?
The Verve Biosciences helps patients in accessing or importing EPCLUSA (sofosbuvir and velpatasvir), not approved in their home country against the legitimate prescription and in conformity with the all local laws and regulations of their home country.
